The present disclosure provides hyperloaded yeast particles. The disclosure further provides methods of making hyperloaded yeast particles and methods of using hyperloaded yeast particles.

The present invention provides a pharmaceutical composition including one or more cannabinoids, and methods of using same, such as for treating NOTCH-related diseases.

A CBD mineral salve containing hemp oil, at least one carrier oil, and suspended magnesium is disclosed. Methods of using and making the CBD mineral oil are also disclosed.

A method of treating Tourette syndrome or a tic disorder in a subject, whereby the subject in need thereof is administered, via the oral mucosa, a bioefficient rapidly infusing composition that includes (a) a pharmaceutically acceptable binder and/or excipient system containing gelatin and a sugar alcohol, and (b) a therapeutically effective amount of cannabidiol (CBD) or a derivative/analog thereof.

A method of treating epilepsy in a subject, whereby the subject in need thereof is administered, via the oral mucosa, a rapidly infusing composition that includes (a) a pharmaceutically acceptable binder and/or excipient system containing gelatin and a sugar alcohol, and (b) a therapeutically effective amount of cannabidiol (CBD) or a derivative/analog thereof.

Disclosed are compositions comprising a honey, a cannabinoid, and an emulsifier, and compositions comprising methylglyoxal, a cannabinoid and an emulsifier. The emulsifier is preferably cyclodextrin. The composition is stabilised such that the rate of degradation of the active components in honey, including methylglyoxal and dihydroxyacetone, is reduced. The composition is also physically stabilised such that the rate of separation of the cannabinoid is reduced and the homogeneity of the composition is maintained over time.

An antiviral cannabinoid-containing thermoresponsive sol-gel formulation and its use in the treatment or prevention of viruses such as Coronaviruses. In particular embodiments, the cannabinoid containing thermoresponsive sol-gel formulation is adapted for nasal delivery and comprises a micellar composition comprising a cannabinoid composition having at least 70% cannabidiol (CBD).

A method of treating Alzheimer's disease and/or other neurodegenerative disorder in a subject, whereby the subject in need thereof is administered, via the oral mucosa, a rapidly infusing composition that includes (a) a pharmaceutically acceptable binder and/or excipient system containing gelatin and a sugar alcohol, and (b) a therapeutically effective amount of cannabidiol (CBD) or a derivative/analog thereof.

Provided herein are compositions comprising cannabinoid cyclodextrin inclusion complex compressed with effervescing agents, and having enhanced dissolution, dispersion and shelf-life, as well as methods of use thereof. The methods include methods of producing cannabinoid inclusion complexes dispersed in solutions, and method of making cannabinoid-infused food products or beverages using the self-emulsifying compositions of cannabinoid cyclodextrin inclusion complex.

The present technology relates to a method of treating one or more behavioral symptoms of Fragile X Syndrome in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of Fragile X Syndrome are treated in the subject.